Full-Time

Executive Assistant

Human Resources

Posted on 3/13/2025

Blueprint Medicines

Blueprint Medicines

501-1,000 employees

No salary listed

Expert

Cambridge, MA, USA

Category
Executive Support
Administrative & Executive Assistance
Human Resources
People & HR
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets
Requirements
  • Minimum 10 years of experience as an executive assistant or related role in a high-growth, fast-paced environment is required (preferably working in partnership with CPO/CHRO or C-Suite).
  • Strong technical aptitude with exceptional skills to enable a hybrid way of working, including proficiency in video conferencing/hybrid-meeting set-up, Power Point, Excel, Word, Outlook, Access or other database and platform systems.
Responsibilities
  • Act as a strategic productivity partner by adeptly managing complex and dynamic senior leader business engagement and proactively anticipating the needs of the Chief People Officer (CPO) and three additional global senior HR leaders as well as cross-global coordination with an additional senior HR leader based in Europe.
  • Expertly manage dynamic executive calendars (in collaboration with administrative peers) to ensure streamlined coordination across internal and external meetings. Anticipate and address future meeting needs based on work priorities, calendar trends and travel schedules, aligning functional priorities with meeting requests to optimize overall workflow and communication.
  • Serve as the central hub for the HR function by meticulously organizing and centralizing documentation and information for easy access and transparency while acting as a go-to resource ensuring timely and secure handling of sensitive and confidential materials. Guide team members to relevant resources, collaborate on evolving information flow processes, and oversee all aspects of departmental information management to enhance efficiency and coordination.
  • Act as a key brand ambassador and representative for the Human Resources function and Blueprint Medicines, embodying and promoting the organization’s values and culture in all communications, events, and interactions with internal stakeholders and external partners.
  • Prioritize, plan, and execute high-impact strategic and special projects, including preparation of presentations, organization of events, coordination of offsite meetings, and facilitation of team activities.
  • Gather data from multiple stakeholders and consolidate it into well-organized information packages to support senior leadership and Board of Directors meetings, ensuring thorough preparation and alignment with organizational objectives and deadlines.
  • Plan and organize data to create and prepare meeting materials, correspondence, agendas, meeting minutes, and resolutions. Develop and maintain comprehensive trackers to oversee and manage post-meeting actions, ensuring thorough follow-up and effective pull-through of key outcomes.
  • Collaborate cross-functionally to effectively manage PO submittals, contract administration, and invoice processing while serving as the liaison to the external vendor.
  • Ensure the precise and timely initiation of expense reports, directly connecting expenses to budgetary guidelines and implement a rigorous tracking system to monitor expenditures, ensuring budget adherence, and financial accuracy in partnership with Financial Planning & Analysis partner.
  • Strategically plan travel itineraries considering travel time, time zones and locations to optimize efficiency and then manage all corresponding travel logistics including, at time, visas and other travel documentation as well as unexpected changes with exceptional accuracy.
  • Apply critical thinking and a “one team” mindset to connect information across teams, offering innovative solutions and creative ideas to address gaps or challenges, enhancing overall team cohesion and performance.
  • Independently manage projects from conception to completion with a high level of discretion, practical judgment, and technical expertise when needed, leveraging a deep understanding of the company in close partnership with CPO and other functions.
  • Serve as a member of the Administrative team, actively participating in and contributing to regular Administrative Team meetings by suggesting agenda topics, leading or engaging in discussion topics, and collaborating with peers on HR annual cycles and employee programs.
  • Demonstrate adaptability and a proactive attitude by willingly contributing to ad-hoc company initiatives and supporting diverse projects in parallel with each other as needed.
Desired Qualifications
  • Experience in HR function and understanding of HR programs and processes strongly preferred.
  • Experience with HR software platforms and reporting tools preferred.
  • Proactive self-starter with a demonstrated talent for building and nurturing relationships, excelling in fostering strong connections and driving collaborative efforts through exceptional commitment, ownership, and teamwork.
  • Forward looking thinker, who actively seeks opportunities and is solution-oriented with strong decision-making capability and translates this into proactive action.
  • Possess strong communication skills and emotional maturity to interact effectively with internal and external partners as a brand ambassador for Blueprint Medicines and the Human Resources function, while collaborating with administrative professionals and the broader employee base to support company-wide and HR-led initiatives and events.
  • Acts as a trusted advisor with a high degree of tact, diplomacy, judgment, and discretion at all employee levels, while handling sensitive information with confidentiality and the utmost integrity.
  • Consistently meet deadlines and prioritize assignments while juggling multiple tasks in a fast-paced, complex environment, demonstrating strong attention to detail that enhances clarity and organization for others.
  • A collaborative communicator who engages openly and transparently, delivering clear, comprehensive, and timely information while actively listening and encouraging meaningful dialogue and feedback.
  • Demonstrated ability to creatively develop and deliver compelling content and communication that effectively build awareness and drive action, leveraging innovative approaches to engage diverse audiences.
  • Exhibit inherent learning agility by quickly adapting to new situations, embracing novel ideas, and displaying curiosity and openness to diverse perspectives.
  • Demonstrate resilience and flexibility in thinking and behaviors, effectively navigating change and challenges while remaining open and being part of evolving processes and solutions.

Company Size

501-1,000

Company Stage

IPO

Headquarters

Cambridge, Massachusetts

Founded

2011

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing demand for targeted therapies boosts Blueprint Medicines' market potential.
  • FDA initiatives expedite approval for Blueprint's innovative systemic mastocytosis treatments.
  • Increasing systemic mastocytosis prevalence aligns with Blueprint's therapeutic focus.

What critics are saying

  • Competition from Deciphera Pharmaceuticals' KIT inhibitor, ripretinib, poses a market threat.
  • Stringent European regulations may hinder Blueprint's market expansion.
  • Potential patent expirations could lead to generic competition and revenue loss.

What makes Blueprint Medicines unique

  • Blueprint Medicines leads in mast cell-targeted therapies with AYVAKIT and BLU-808.
  • AYVAKIT shows long-term efficacy and safety in treating indolent systemic mastocytosis.
  • BLU-808 offers a wide therapeutic window as a first-in-class oral KIT inhibitor.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Unlimited Paid Time Off

Commuter Benefits

Mental Health Support

Employee Stock Purchase Plan

Parental Leave

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

1%
ETF Daily News
Mar 8th, 2025
Proficio Capital Partners LLC Makes New $1.01 Million Investment in Blueprint Medicines Co. (NASDAQ:BPMC)

Proficio Capital Partners LLC makes new $1.01 million investment in Blueprint Medicines Co. (NASDAQ:BPMC).

Defense World
Mar 7th, 2025
Truist Financial Corp Makes New Investment in Blueprint Medicines Co. (NASDAQ:BPMC)

Truist Financial Corp makes new investment in Blueprint Medicines Co. (NASDAQ:BPMC).

Medical Update Online
Mar 4th, 2025
Blueprint Medicines highlights 'decade of leadership' in Mast Cell research with new AYVAKIT and BLU-808 data at AAAAI/WAO 2025

Blueprint Medicines highlights 'decade of leadership' in Mast Cell research with new AYVAKIT and BLU-808 data at AAAAI/WAO 2025.

PR Newswire
Feb 28th, 2025
Blueprint Medicines Highlights Leading Portfolio Of Mast Cell-Targeted Therapies At 2025 Aaaai / Wao Joint Congress

-- Updated data show AYVAKIT® (avapritinib) was safe and effective for long-term treatment of ISM, with sustained symptom and quality-of-life benefit and no new safety signals with multiple years of therapy ---- AYVAKIT-treated patients achieved improvements in bone health based on an analysis of bone mineral density scans, underscoring the importance of treating patients early in the ISM disease course ---- BLU-808 healthy volunteer trial results demonstrate wide therapeutic window for modulating mast cell activity, affirming potential as best- and first-in-class oral wild-type KIT inhibitor --CAMBRIDGE, Mass., Feb. 28, 2025 /PRNewswire/ -- Blueprint Medicines Corporation (Nasdaq: BPMC) today announced data presentations reflecting its ongoing efforts to innovate the treatment of mast cell-driven diseases. The presentations include three-year median follow-up data from the registrational PIONEER trial demonstrating the strong long-term efficacy and safety of AYVAKIT® (avapritinib) in patients with indolent systemic mastocytosis (ISM), and real-world evidence further characterizing the substantial burden of the disease, highlighting the urgency to treat. In addition, the company will report positive data from the Phase 1 healthy volunteer trial evaluating BLU-808, an investigational, highly potent and selective oral inhibitor of wild-type KIT, consistent with top-line data previously announced in January 2025. A total of 14 data presentations, including two oral presentations, will be reported at the 2025 American Academy of Allergy, Asthma & Immunology (AAAAI) / World Allergy Organization (WAO) Joint Congress being held February 28-March 3 in San Diego."We are incredibly proud to showcase our mast cell therapy portfolio at AAAAI / WAO, with 14 presentations highlighting more than a decade of leadership and collaboration with the mast cell disease community, including renowned medical institutions pioneering innovative research and multi-disciplinary patient care," said Becker Hewes, M.D., Chief Medical Officer at Blueprint Medicines. "In ISM, new data have reinforced that AYVAKIT was very well-tolerated after multiple years of treatment, with a low discontinuation rate and safety results that have remained consistent with the safety profile from the placebo-controlled study as summarized in the FDA-approval label

Defense World
Feb 17th, 2025
Blueprint Medicines Corporation Reports Strong Financial Results for 2024

Furthermore, Blueprint Medicines announced the appointment of Sherwin Sattarzadeh as Chief Business Officer, succeeding Helen Ho.